Biosenta Inc. (CSE: ZRO)
Canada
· Delayed Price · Currency is CAD 0.105
0.00 (0.00%)
Nov 22, 2024, 4:00 PM EST
Biosenta Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
| Revenue | 0.2 | 0 | 0 | 0.17 | 0 | - | Upgrade
|
| Revenue Growth (YoY) | 22456.68% | -9.47% | -99.32% | 10887.25% | - | - | Upgrade
|
| Cost of Revenue | 0 | 0 | 0.03 | 0.08 | 0 | - | Upgrade
|
| Gross Profit | 0.2 | -0 | -0.03 | 0.09 | 0 | - | Upgrade
|
| Selling, General & Admin | 1.14 | 1.41 | 1.08 | 2.02 | 0.67 | 0.44 | Upgrade
|
| Research & Development | 0.08 | 0.07 | 0.1 | 0.08 | 0.03 | 0.04 | Upgrade
|
| Operating Expenses | 1.22 | 1.48 | 1.19 | 2.1 | 0.7 | 0.49 | Upgrade
|
| Operating Income | -1.02 | -1.48 | -1.22 | -2.01 | -0.7 | -0.49 | Upgrade
|
| Interest Expense | -0.85 | -0.06 | -0.22 | -0.01 | -0.04 | -0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | 0 | -0.01 | -0 | -0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.08 | 0.03 | -0.01 | -0.02 | -0.02 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -1.95 | -1.51 | -1.46 | -2.04 | -0.77 | -0.53 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.79 | -4.79 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.01 | - | Upgrade
|
| Pretax Income | -6.74 | -6.3 | -1.46 | -2.04 | -0.76 | -0.53 | Upgrade
|
| Net Income | -6.74 | -6.3 | -1.46 | -2.04 | -0.76 | -0.53 | Upgrade
|
| Net Income to Common | -6.74 | -6.3 | -1.46 | -2.04 | -0.76 | -0.53 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 26 | 21 | 18 | 16 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 26 | 21 | 18 | 16 | 14 | Upgrade
|
| Shares Change (YoY) | 42.62% | 22.74% | 19.71% | 11.27% | 13.74% | 6.85% | Upgrade
|
| EPS (Basic) | -0.22 | -0.24 | -0.07 | -0.11 | -0.05 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.22 | -0.24 | -0.07 | -0.11 | -0.05 | -0.04 | Upgrade
|
| Free Cash Flow | -0.87 | -0.57 | -0.5 | -0.67 | -0.32 | -0.33 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.02 | -0.02 | -0.04 | -0.02 | -0.02 | Upgrade
|
| Gross Margin | 99.74% | -291.36% | - | 54.23% | 3.59% | - | Upgrade
|
| Operating Margin | -507.11% | -142275.24% | -105790.62% | -1194.37% | -46046.34% | - | Upgrade
|
| Profit Margin | -3353.66% | -604582.92% | -126695.13% | -1214.64% | -49797.91% | - | Upgrade
|
| Free Cash Flow Margin | -430.66% | -54351.92% | -43825.63% | -399.92% | -20897.32% | - | Upgrade
|
| EBITDA | - | - | - | - | - | -0.49 | Upgrade
|
| D&A For EBITDA | - | - | - | - | - | 0 | Upgrade
|
| EBIT | -1.02 | -1.48 | -1.22 | -2.01 | -0.7 | -0.49 | Upgrade
|
| Revenue as Reported | - | - | - | 0.17 | 0 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.